Subject: FBCD Announces International Interest Growing for COCO-AMO

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
FBCD Announces International Interest Growing for COCO-AMO
Hot Stock to WatchHot Stock to Watch

Company: Terra Tech Corp (OTCQB: TRTC)

End of Day:

Price: 0.263

Change (%): + 0.001 (0.38)

Volume: 608,717
TRTC Chart

Terra Tech Corp. (TRTC) through its wholly-owned subsidiary GrowOp Technology, specializes in controlled environment agricultural technologies. The company integrates best-of-breed hydroponic equipment with proprietary software and hardware to provide sustainable solutions for indoor agriculture enterprises and home practitioners. Our complete product line is available at specialty retailers throughout the United States, and via our website. Through its wholly-owned subsidiary Edible Garden, cultivates a premier brand of local and sustainably grown hydroponic produce, sold through major grocery stores such as Shoprite, Food Emporium and others throughout New Jersey, New York, Delaware, Maryland, Connecticut, and Pennsylvania. MediFarm LLC is focused on securing permits to operate medical cannabis businesses in Nevada.

Company Information Sheet

Top PerformerYesterday's Top Performer

FBC Holding Inc. (Pink Sheets: FBCD)

End of Day:

Price: 0.0003

Change (%): + 0.0001 (50.00)

Volume: 12,544,250
TRTC Chart

Darian Braun and FBC Holding, Inc. announce COCO-AMO gaining more International interest from Distributors

Darian Braun and COCO-AMO continue their successful roll-out and international interest from the Netherlands, Australia and others

NEW YORK, Dec. 29, 2014 /PRNewswire/ - FBC Holding, Inc. (OTC: FBCD) an international product development company and its retail health and beauty holding, COCO-AMO announced they are receiving interest from other distributors in the Netherlands, Australia and other European markets.

Darian Braun, Founder and President of COCO-AMO, stated “This is all very exciting. The products are providing incredible results and that is really important. As soon as a distributor calls us, we get them samples out to review. The next call we get, is them saying they want to buy and support our product line. How great is that!”

Continue Reading

Other Small Cap News

Company: mCig®, Inc. (OTCBB: MCIG)

mCig Forms Oregon Subsidiary, CannaProTech, LLC

BEVERLY HILLS, Calif., Dec. 29, 2014 (GLOBE NEWSWIRE) -- mCig®, Inc. (OTCBB:MCIG) ("mCig"), a technology company that owns, manufactures, and distributes the mCig®, VitaCig®, and Vapolution products, is pleased to announce that the Company has formed a 100%-owned subsidiary, CannaProTech, LLC., in the state of Oregon for the purpose of processing and distributing cannabis and derivatives, along with future expansion into recreational retail locations. CannaProTech will also assist in the development of the mCig+ line of products, which will provide mobile vaporization in applications for the delivery of cannabis plant derivatives (CBD).

mCig, Inc. and CannaProTech, LLC are nearing conclusive agreements with two reputable and long established Medical Marijuana growers in Oregon with large, productive organic cannabis farms. These agreements will allow for CannaProTech to directly obtain medical-grade cannabis for use in extractions, distribution, and retail sales.

Continue Reading

Company: Amarantus BioScience Holdings, Inc. (OTCQB: AMBS)

Amarantus to Present LP-002 Data for Alzheimer's Blood Diagnostic LymPro Test(R) at Biotech Showcase 2015 Conference on January 14, 2015

SAN FRANCISCO and GENEVA, Dec. 29, 2014 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the development of diagnostics in Alzheimer's disease and therapeutic products in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, announced it will be presenting a corporate overview including top-line results of its expanded LP-002 study of the Lymphocyte Proliferation Test (LymPro Test®) blood diagnostic for Alzheimer's disease (AD) at Biotech Showcase 2015. Gerald E. Commissiong, President & CEO of Amarantus, will present on Wednesday, January 14, 2015 at the Parc 55 Wyndham Union Square in San Francisco, CA.

Event: Biotech Showcase 2015
Date: Wednesday, January 14, 2015
Time: 3:30 p.m. Pacific Time / 6:30 p.m. Eastern Time
Location: Parc 55 Wyndham Union Square, San Francisco, CA

Continue Reading

Market News

By Evelyn Cheng: CNBC

US stocks open lower; Greek elections eyed

U.S. stocks opened slightly lower on Monday, amid some pressure on European stocks from Greece's failure to elect a president in a third round of elections.

"Obviously the Greek elections are weighing on the markets, obviously a natural reaction after strong gains last week," said Peter Cardillo, chief market economist at Rockwell Global Capital.

He expected U.S. stocks to hold within a range or trade mixed on Monday.

Continue Reading

By Anthony Mirhaydari:
The Fiscal Times

How Demographics Could Doom the Bull Market

In the popular perception of economics, some things are taken to be self-evident. Like the truism that investors should just buy and hold stocks for the long term. Or that prosperity is attainable through hard work, saving and home ownership. Or that a college education is the path to personal empowerment.

But the truth is, our history is limited. The Baby Boomer generation - the 76 million Americans born between 1946 and 1964 - was the first to really live a full lifecycle in the economy as currently structured. Members of the Greatest Generation were paying their mortgages when the value of the U.S. dollar was still tied to gold. Before that, folks remembered what it was like when there was no Federal Reserve - or federal income taxes, for that matter.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks